368
Bearbeitungen
Endokarditis: Unterschied zwischen den Versionen
→Therapie bei Staphylokokken (MSSA)
| Zeile 313: | Zeile 313: | ||
| | | | ||
| class="mbox-image"| [[Image:Ambox_important_orange.svg.png|42px]] | | class="mbox-image"| [[Image:Ambox_important_orange.svg.png|42px]] | ||
| style="padding: 0.25em 0.5em; width: 100%;" |Vancomycin (Glykopeptide) sind ß-Laktam-Antibiotika signifikant unterlegen. Alternativen: Daptomycin und Teicoplanin | | style="padding: 0.25em 0.5em; width: 100%;" |Vancomycin (Glykopeptide) sind ß-Laktam-Antibiotika signifikant unterlegen<ref>Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe | ||
KW. Outcome of vancomycin treatment in patients with | |||
methicillin-susceptible Staphylococcus aureus bacteremia. | |||
Antimicrob Agents Chemother 2008;52:192−197.</ref>. Alternativen: Daptomycin und Teicoplanin | |||
|} | |} | ||
<br> | <br> | ||